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Abstract
Sterile inflammation is a host response to tissue injury that is mediated by damage-associated
molecular patterns (DAMPs) released from dead cells. Sterile inflammation worsens damage in a
number of injury paradigms. The pro-inflammatory cytokine interleukin-1α (IL-1α) is reported to
be a DAMP released from dead cells, and is known to exacerbate brain injury caused by stroke. In
the brain, IL-1α is produced by microglia, the resident brain macrophages. We found that IL-1α is
actively trafficked to the nuclei of microglia, and hence tested the hypothesis that trafficking of
IL-1α to the nucleus would inhibit its release following necrotic cell death, limiting sterile
inflammation. Microglia subjected to oxygen-glucose deprivation (OGD) died via necrosis. Under
these conditions, microglia expressing nuclear IL-1α released significantly less IL-1α than
microglia with predominantly cytosolic IL-1α. The remaining IL-1α was immobilised in the
nuclei of the dead cells. Thus, nuclear retention of IL-1α may serve to limit inflammation
following cell death.
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Introduction
Sterile inflammation is a host response to tissue injury that can exacerbate the initial insult
[1]. Intracellular molecules released from necrotic cells act as damage-associated molecular
patterns (DAMPs), signalling to the innate immune system that tissue injury has occurred
[2]. Interleukin-1α (IL-1α), a pro-inflammatory member of the IL-1 cytokine family [3], has
recently been identified as a DAMP released from necrotic cells [4]. In addition, necrotic
cell DAMPs are reported to stimulate IL-1α production by immune cells, which further
exacerbates sterile inflammation [1]. Experimental stroke in rodents elicits an inflammatory
response that markedly exacerbates brain injury [5]. IL-1α is a key contributor to this injury,
and its genetic ablation (along with IL-1β, a related cytokine) causes a 70% reduction in the
brain injury caused by stroke [6].
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In the brain after injury (e.g. stroke, haemorrhage, trauma), IL-1 family cytokines are
produced by microglia, the resident brain macrophages [7]. IL-1α is produced in the cytosol
as a 31 kDa protein that, following release from necrotic cells, activates the type I IL-1
receptor on responsive cell membranes [8;9]. The N-terminal domain of IL-1α contains a
nuclear localization sequence (NLS) which mediates active nuclear import [10;11]. IL-1α
has been reported to act within the nucleus to regulate cytokine transcription and RNA
splicing [12;13]. In this study we sought to test the hypothesis that IL-1α nuclear import
also inhibits IL-1α release following necrotic cell death. We report that IL-1α nuclear
import and intranuclear retention reduce IL-1α release from necrotic microglia. Thus, IL-1α
nuclear retention by necrotic cells may inhibit injury-induced inflammation.
Results
IL-1α nuclear localization is inhibited at high cell density
In order to investigate the effects of IL-1α nuclear localisation on IL-1α release after
necrotic cell death, we set out to identify factors regulating IL-1α nuclear localisation. We
have reported previously that IL-1α is located predominantly within the nucleus in both
primary cultured murine microglia and BV-2 cells [a microglial cell line, [11]]. These cells
were cultured at a relatively low cell density (1 × 105 cells/mL). We observed that when the
microglia were cultured at higher densities (3.5 - 5 × 105 cells/mL) and treated with
lipopolysaccharide (LPS, bacterial endotoxin, used to enhance IL-1 expression, 1 μg/mL, 6
hours) IL-1α was predominantly cytosolic (Fig 1Aiii). Local cell density varied within
individual cultures, and the proportion of cells containing intranuclear IL-1α appeared to
vary with cell density (e.g. compare DAPI in Fig. 1Aii vs. iii).
On the basis of these data, we tested the initial hypothesis that nuclear localization of IL-1α
is regulated by cell density. BV-2 microglia were seeded at different densities prior to LPS
treatment and IL-1α immunostaining. The proportion of IL-1α-positive BV-2 cells
containing intranuclear IL-1α was quantified and correlated with the local cell density in
individual microscope fields of view. The proportion of IL-1α-expressing cells containing
nuclear IL-1α decreased significantly as cell density increased (R2 = 0.49, p<0.0001 vs.
slope of zero, Fig. 1B), confirming that nuclear localization of IL-1α in BV-2 microglia was
inhibited at high cell density.
We next sought to identify which changes in the local microenvironment at high cell density
were responsible for inhibiting IL-1α nuclear localisation (changes in secreted mediators, in
the abundance of extracellular matrix (ECM), or in the extent of direct cell-cell contacts).
Mediators released from microglia cultured at high density in a transwell insert, above
microglia cultured at low density, did not affect IL-1α nuclear localization in the low
density cells (Fig. 1C). IL-1α nuclear localization in low density BV-2 microglia was also
unaltered when cells were cultured on laminin [part of the brain ECM, [14]] or fibronectin
[extravasated after brain injury, [15], Fig. S1]. However, we found that IL-1α sub-cellular
distribution was regulated by cell-contact. Co-culture of low density BV-2 microglia with a
confluent HEK-293 cell monolayer (used as a source of generic non-myeloid, non-murine
cells) induced a marked change in the subcellular distribution of IL-1α in BV-2 cells, from
being both nuclear and cytosolic (Fig. 1Di) to being exclusively cytosolic (Fig. 1Dii). This
redistribution of IL-1α occurred in the majority of BV-2 microglia (% cells with
intranuclear IL-1α fell from 98 ± 2 % to 10 ± 4 %, p<0.0001, Fig. 1E). Microglial IL-1α
nuclear localization was similarly inhibited by co-culture of primary murine microglia with
HEK-293 cells, or with primary murine astrocytes (Fig S2). Thus, IL-1α nuclear localization
in microglia is inhibited at high cell density via a generic cell contact-dependent mechanism.
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Intranuclear IL-1α is retained by necrotic microglia
Since IL-1α release from necrotic cells is pro-inflammatory [4], we hypothesised that IL-1α
nuclear localization represents a mechanism to inhibit IL-1α release, and so inhibit
inflammation induced by necrotic cells. Thus, the reduced IL-1α nuclear localization in high
density microglia would result in increased IL-1α release after necrosis. We induced
microglial necrosis by oxygen-glucose deprivation (OGD), an in vitro paradigm of stroke
[16].
Necrosis was confirmed in >90% BV-2 microglia, by release of the cytosolic enzyme lactate
dehydrogenase (LDH) from cells (Fig. 2A). Cell density had no effect on the proportion of
microglia undergoing necrosis. In contrast, IL-1α release from necrotic BV-2 microglia was
regulated by cell density. BV-2 microglia cultured at high density released significantly
more of their IL-1α than microglia cultured at low density, where nuclear localization was
greatest (Fig. 2B, 94 ± 25 % released from high density cells in comparison to 40 ± 13 %,
p<0.001). Thus microglia containing nuclear IL-1α prior to a necrotic insult retain a greater
proportion of their IL-1α than microglia containing only cytosolic IL-1α (Fig. 2B).
In order to determine whether the IL-1α retained by necrotic microglia was intranuclear, we
investigated the localization of IL-1α in the remaining adherent BV-2 microglia at the end
of the experiment. Microglia were stained with propidium iodide (PI, a DNA-binding dye
excluded from living cells) and immunostained for IL-1α. BV-2 microglia maintained in
normoxic conditions remained alive (PI-negative) and IL-1α was predominantly
intranuclear in low density cells (Fig. 2Ci) and predominantly cytosolic in high density cells
(Fig. 2Cii). OGD led to the detachment of necrotic BV-2 microglia, and at low density, the
only cells that remained adherent were still alive (PI-negative, Fig. 2Di), preventing
investigation of IL-1α localization in the dead, detached cells. Intranuclear retention of
IL-1α in these dead, detached cells presumably prevented detection in the supernatants by
the IL-1α ELISA (Fig. 2B, low density OGD treated cells). In contrast, in high density
microglia, some dead, PI-positive microglia remained adherent (Fig. 2Dii). Intranuclear
IL-1α was detected in these dead, PI-positive cells, co-localizing with both PI and DAPI.
Since IL-1α is normally cytosolic in these cells (Fig. 2Cii), IL-1α nuclear import must have
occurred during the OGD insult. This may be the result of a gradual loss of cell-cell contacts
as necrotic cells detached. This represents a new mechanism that may reduce IL-1α-induced
sterile inflammation after necrotic cell death.
IL-1α-GFP is retained by necrotic COS-7 cells
To further confirm that IL-1α is retained in necrotic cells, we investigated the retention of
IL-1α-GFP versus GFP alone in necrotic COS-7 cells. IL-1α-GFP or GFP were transiently
overexpressed in COS-7 cells, and the cells were killed by OGD (24 hours) combined with
ATP-depletion by metabolic poisons (1 μM carbonyl cyanide 3-chlorophenylhydrazone
(CCCP) and 15mM 2-deoxyglucose (2-DOG)). Necrotic COS-7 cells detached into the cell
culture media and were analysed by FACS. Dead cells were identified by PI staining and the
amount of IL-1α-GFP retained was quantified in PI-positive cells (Fig. 3Aiii, PI+/GFP+).
IL-1α-GFP fluorescence retention was compared to retention of GFP alone (Fig. 3Aii). The
baseline fluorescence of living, GFP or IL-1α-GFP-expressing cells, dissociated by
trypsinisation, was also quantified.
The mean fluorescence of live GFP-expressing cells was significantly higher than that of
IL-1α-GFP expressing cells (Fig. 3B, 2550 ± 230 AU vs. 1500 ± 90 AU, p<0.001),
indicating that GFP is more highly expressed in these cells than IL-1α-GFP. GFP
fluorescence was reduced following death of both GFP and IL-1α-GFP expressing cells
(Fig. 3B). However, whilst GFP-expressing cells retained only 8% of their fluorescence after
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cell death, IL-1α-GFP expressing cells retained significantly more fluorescence (60% ±
10%, p<0.01, Fig. 3C). These data, combined with the evidence from necrotic microglia
(Fig. 2) confirm that IL-1α can be retained by necrotic cells, potentially regulating sterile
inflammation induced by necrotic cell death.
Nuclear retention of IL-1α by immobilisation
IL-1α can diffuse passively across the nuclear pore complex and so out of the nuclei of
necrotic cells [17]. Thus we hypothesised that in order to be retained in necrotic cells, IL-1α
must become immobilised in cell nuclei. Since OGD will cause cellular ATP depletion prior
to necrosis, we proposed that this immobilisation would occur under conditions of ATP-
depletion. Thus, we investigated IL-1α-GFP intranuclear mobility in COS-7 cells
maintained under normal (glucose-maintained) and ATP-depleted (glucose-free imaging
buffer + 1 μM CCCP and 15 mM 2-DOG, 30 minutes) culture conditions.
In control, glucose-maintained cells, both GFP and IL-1α-GFP were distributed evenly
throughout the nucleoplasm (Fig. 4Ai). As has been reported previously [18], ATP depletion
induced chromatin rearrangement (Fig. 4Aii, DAPI stain). However, the intranuclear
distribution of GFP was unaffected in ATP-depleted cells (Fig. 4Aii). In contrast, ATP
depletion stimulated the redistribution of intranuclear IL-1α-GFP to discrete speckles (Fig.
4Aii).
The nucleoplasmic mobility of IL-1α-GFP was investigated by FRAP. A nucleoplasmic
region of interest (ROI, Fig. 4Bi, ii) was defined within a GFP-positive cell and
photobleached. The kinetics of fluorescence recovery (due to exchange of bleached with
unbleached fluorescent molecules in the surrounding nucleoplasm) was followed within the
ROI (Fig 4Bi, ii). A one-phase exponential recovery curve was then fit to the fluorescence
recovery data (Fig. 4C) and used to calculate the half-time (t1/2, 4D) for fluorescence
recovery [19]. ATP depletion significantly attenuated IL-1α-GFP intranuclear mobility (Fig.
4D, t1/2 increased from 1.5 ± 2.8 seconds in glucose-maintained cells to 11.6 ± 4.4 seconds
in ATP-depleted cells, p<0.001). In contrast, the intranuclear mobility of GFP was
unaffected by ATP depletion (Fig. 4D, t1/2 = 0.6 ± 0.2 seconds for GFP in control cells). The
cytoplasmic mobility of GFP and IL-1α-GFP were also unaffected by ATP depletion (Fig.
S3) Thus, ATP depletion caused the specific immobilisation of intranuclear IL-1α-GFP in
discrete speckles.
We next investigated the nature of the sub-nuclear domains to which IL-1α-GFP became
confined under ATP-depleted conditions. The co-localization of IL-1α-GFP with DNA and
specific nuclear proteins was assessed in ATP-depleted cells by immunocytochemistry and
confocal microscopy. Co-localization was quantified using the Pearson’s co-localization
coefficient, which assesses the strength of linear correlation between pixel fluorescence in
two different channels. +1 indicates perfect co-localization, a value of zero indicates no co-
localization, and −1 indicates a perfect negative correlation between the intensities in the
two channels [20].
The IL-1α N-terminal domain has been reported previously to localize to SC-35-positive
nuclear speckles [storage sites for RNA splicing factors, [13;21]]. We found that IL-1α-GFP
similarly became partially restricted to SC-35-poitive nuclear speckles in ATP-depleted cells
(Fig. 5, Pearson’s coefficient = 0.68 ± 0.09). IL-1α-GFP also co-localized partially with the
histone acetyl transferase p300 (Fig. 5, Pearson’s coefficient = 0.62 ± 0.07), an intranuclear
protein known to interact with IL-1α [22]. In contrast, IL-1α-GFP co-localized poorly with
active transcription sites labelled with serine-2-phosphorylated C-terminal domain repeat
RNA polymerase II [PolII0, Fig. 5, Pearson’s coefficient = 0.38 ± 0.15, [23;24]]. IL-1α-
GFP was also excluded from regions containing heterochromatic DNA (Fig. 5, Pearson’s
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coefficient = −0.10 ± 0.15). These data indicate that ATP depletion enhances the previously
reported associations of IL-1α with p300, and with RNA splicing factors [13;22]. These
enhanced interactions may be responsible for the immobilisation of IL-1α-GFP that occurs
after ATP-depletion and thus for IL-1α retention in the nucleus after necrotic cell death.
Discussion
We report here that IL-1α can be retained in cell nuclei following necrotic cell death (Figs. 2
and 3). The finding that IL-1α can be immobilised in nuclear speckles with p300 following
ATP depletion provides a potential mechanism for the intranuclear retention of IL-1α in
necrotic cells (Figs. 4 and 5).
Since IL-1α released from necrotic cells is proinflammatory [4], we propose that
intranuclear retention of IL-1α represents a mechanism for attenuating inflammation caused
by the death of IL-1α-expressing cells. IL-1α is expressed by healthy cells in some tissues
including skin, liver and spleen [25-27]. IL-1α released from these cells after tissue damage
acts as a DAMP activating sterile inflammation [4]. IL-1α expression is also induced in
immune cells by DAMPs [1], and will be released from immune cells following necrosis.
Intranuclear retention of IL-1α may therefore both inhibit the induction of sterile
inflammation and negatively regulate the continuing inflammatory response.
High mobility group box 1 (HMGB1), like IL-1α, is a nuclear protein that can regulate
transcription, and can also be released from cells to act as a pro-inflammatory cytokine [28].
Scaffidi et al. (2002) [29] report that HMGB1 can be retained in apoptotic cell nuclei,
limiting cell-death induced inflammation, via binding to hypoacetylated chromatin. While
IL-1α is similarly retained in cell nuclei, we have found that this retention occurs in necrotic
cells (confirmed by LDH release and PI staining, Figs. 2 and 3). Furthermore, IL-1α
intranuclear retention does not appear to depend on chromatin binding, as immobilised
IL-1α-GFP did not co-localize with DAPI-stained DNA (Figs. 4 and 5). Instead, our data
(Fig. 5) suggests that IL-1α retention in the nucleus is more likely to depend on previously
reported interactions with other intranuclear proteins; p300 and RNA splicing factors
[13;22].
In summary, the results presented here provide new insights in to mechanisms regulating
IL-1α-dependent inflammation after necrotic cell death. Future studies are required to




BV-2, HEK-293 and COS-7 cells were maintained as described previously [11;19].
Confluent monolayers of HEK-293 cells were grown on poly-D-lysine-coated coverslips,
prior to the addition of BV-2 cells (1 × 105 cells/mL) on top of the monolayers. IL-1α
expression in BV-2 microglia was induced with LPS (1 mg/mL, Escherichia coli 026:B6).
COS-7 cells were ATP depleted by treatment with 1 μM CCCP + 15 mM 2-DOG (30
minutes) in glucose-free DMEM (OGD experiments, Invitrogen, UK) or imaging buffer
[FRAP experiments, [19]]. IL-1α-GFP and GFP expression vectors [11] were transiently
transfected into COS-7 cells using lipofectamine 2000 (Invitrogen).
Immunocytochemistry
BV-2 cells in HEK co-cultures were labeled with Alexa Fluor 594 conjugated isolectin B-4
(5 μg/mL, 15 minutes prior to fixation, Invitrogen). Necrotic cells were stained with PI (20
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μg/mL, 5 minutes). Immunocytochemistry was performed as described previously [11],
using goat anti-IL-1α (RnD Systems, UK), mouse anti-p300, rabbit anti-PolII0 (Abcam,
UK) or mouse anti-SC35 (Sigma Aldrich, UK) antibodies.
Widefield microscopy and cell counting
Widefield images were captured on a BX51 upright microscope (40×/1.00 UPlan Apo
objective, Olympus, UK) with a Coolsnap HQ camera (Photometrics, UK) and MetaVue
Software (Molecular Devices, UK). Image scaling was adjusted using Image J software
(http://rsb.info.gov/ij/) to exclude background immunostaining. Local cell density (density
of DAPI-stained nuclei) and % IL-1α-expressing cells containing intranuclear IL-1α were
quantified by blinded, manual cell counting in 8-10 fields of view per coverslip.
OGD, LDH Assay and IL-1α ELISA
BV-2 or COS-7 cells in glucose-free DMEM (Invitrogen) were transferred to a humidified
hypoxic chamber (1% O2, 5% CO2, 37°C, 24 hours, Coy Laboratory Products, UK).
Normoxic cells were maintained in DMEM with glucose under normal tissue culture
conditions. LDH and IL-1α release into supernatants was quantified using a CytoTox 96®
Non-Radioactive Cytotoxicity Assay (Promega, UK) and an anti-IL-1α DuoSet ELISA
(RnD Systems, UK) respectively, according to manufacturer’s instructions.
FACS
GFP fluorescence in PI-stained COS-7 cells was quantified using a Cyan ADP flow
cytometer (Beckman Coulter, UK). Fluorophores were excited with a 488nm laser and
emission was detected though 530/40 (GFP) and 613/20 (PI) bandpass filters. Data analysis
used Summit v4.3 software (Dako, USA). Compensation was applied for spillover between
the two fluorescence signals, using PI-positive/GFP-negative (untransfected, dead, PI-
stained), and PI-negative/GFP-positive (transfected, live, no PI staining) cells for
calibration. Mean GFP fluorescence was measured in GFP/PI double-positive cells.
Confocal microscopy and FRAP
Confocal microscopy on fixed cells and FRAP on live cells were performed on a Leica SP5
AOBS tandem head confocal microscope (63×/1.40 HCX PL Apo objective) with Leica
LAS AF software as described previously [11]. Pearson’s co-localization analysis was used
to assess the co-localization of IL-1α-GFP with nuclear proteins and DAPI [20].
For nucleoplasmic FRAP, cells were maintained in 5% CO2 at 36°C, and imaged at 5 ×
zoom using the 488nm laser line (8% power) of an argon laser (set to 80% power). A
nucleoplasmic ROI (4 × 4 μm) was defined, and 20 pre-bleach 256 × 256 pixel images were
acquired followed by 10 ROI bleach cycles (frames captured while zoomed in on ROI and
using 100% of 458, 476 and 488 nm laser line power) over 3.8 s. Recovery was followed
over 100 frames acquired at 2.6 frames/s, and then over a further 100 frames acquired every
2 seconds when recovery was slow. Protein mobility (t1/2) was calculated as reported
previously [19;30].
Statistical analysis
Statistical analyses were performed using GraphPad Prism version 4.00 for Windows, from
GraphPad Software (USA, www.graphpad.com). Differences between two groups were
identified using the Student’s t-test, and differences between several groups were identified
using one -way analysis of variance (ANOVA) with post-hoc Bonferroni multiple
comparison test. All data are expressed as mean ± standard deviation (s.d.).
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DAMP damage-associated molecular pattern
2-DOG 2-deoxyglucose
ECM extracellular matrix
FRAP fluorescence recovery after photobleaching
HMGB1 high mobility group box 1
LDH lactate dehydrogenase
LPS lipopolysaccharide
OGD oxygen and glucose deprivation
PI propidium iodide
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Figure 1. IL-1α nuclear localization in BV-2 microglia is inhibited by high local cell density
BV-2 microglia were left untreated (Ai) or LPS-treated (Aii, iii, B-E 1 μg/mL, 6 hours),
IL-1α-immunostained (green) and co-stained with DAPI (blue). The % IL-1α-expressing
cells containing nuclear IL-1α in individual fields of view was quantified by blind manual
cell counting (B, C, E). IL-1α was intranuclear in some microglia (Aii, low local cell
density) and cytosolic in others (Aiii, high local cell density) when microglia were cultured
at 3.5 - 5 × 105 cells/mL. IL-1α localization was quantified in individual fields of view from
microglia seeded at 0.25 - 5 × 105 cells/mL, and correlated with local cell density (B).
Individual points represent single fields of view, linear regression line (solid line) R2 = 0.49
p<0.0001 vs. slope of zero. IL-1α localisation was also quantified in low density microglia
(1 × 105 cells/mL) cultured with or without high density microglia (1 × 106 cells/mL) in
transwell inserts (+TW or alone respectively, C). BV-2 microglia (1 × 105 cells/mL,
isolectin B-4 stained, red, IB-4) were cultured alone (Di) or with HEK-293 cells (Dii). IL-1α
localisation was quantified in microglia cultured with (HEK) or without (No HEK, E)
HEK-293 cells. Data from n ≥ 3 independent experiments. Scale bars = 40 μm.
***p<0.0001, Student’s t-test.
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Figure 2. Intranuclear IL-1α is retained by necrotic microglia
BV-2 microglia were seeded at low, medium or high density (1, 5 and 10 × 105 cells/mL
respectively), LPS-treated (1μg/mL, 3 hours) and either kept in normoxic conditions or
killed by 24 hours OGD. % total LDH (A) and IL-1α (B) release into media were
quantified. Data are from n = 6 independent experiments. ***p<0.001 One-way ANOVA
with post-hoc Bonferroni multiple comparison test. Remaining adherent cells in normoxia-
(C) and OGD-treated (D) cultures of low density (Ci, Di) and high density BV-2 cells (Cii,
Dii) were IL-1α-immunostained (green) with PI (red) and DAPI (blue) co-staining. Images
are from one of n = 3 independent experiments. Scale bar = 40 μm.
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Figure 3. IL-1α-GFP is retained by necrotic COS-7 cells
COS-7 cells transiently transfected with GFP or IL-1α-GFP were killed by ATP-depletion
(30 minutes, 1 μM CCCP, 15mM 2-DOG) and OGD (24 hours). Control cells were kept
under normoxic conditions and trypsinised. Necrotic, detached cells and live, trypsinised
cells were collected and PI-stained. Cellular GFP and PI fluorescence was measured by
FACS. Scatter plots (A) show PI and GFP fluorescence intensities of necrotic cells in one
representative experiment. Dashed rectangle indicates PI+/GFP+ cells. Mean GFP
fluorescence of GFP and IL-1α-GFP positive COS-7 cells was measured in live, trypsinised
cells and in dead, PI positive cells (C). *p<0.05, **p<0.01, ***p<0.001, One-way ANOVA
with post-hoc Bonferroni multiple comparison. The proportion of GFP fluorescence retained
on cell death was calculated for GFP- and IL-1α-GFP-expressing cells (D). **p<0.01,
Student’s t-test. Data from n = 3 independent experiments.
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Figure 4. Intranuclear IL-1α is immobilised on depletion of cellular ATP
GFP or IL-1α-GFP-expressing COS-7 cells were ATP depleted (30 minutes, “+ inhibitors”,
Aii, Bii) or maintained in imaging buffer with glucose “+ glucose” Ai, Bi). Confocal images
(Ai, ii) show GFP and IL-1α-GFP intranuclear distribution in DAPI stained cells. Scale bar
= 10 μm. Time-lapse confocal images (B) show fluorescence recovery after photobleaching
of an intranuclear ROI (red square). Scale bar = 5 μm. Mean nucleoplasmic fluorescence
recovery curves (C) and half times (t1/2, D) for fluorescence recovery are shown for GFP
and IL-1α-GFP expressing cells with and without ATP depletion. Data from n = 15
individual cells per construct. ***p<0.001, *p<0.05, One-way ANOVA with post-hoc
Bonferroni multiple comparison test.
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Figure 5. Intranuclear IL-1α co-localizes with nuclear speckles and p300 on depletion of cellular
ATP
IL-1α-GFP-expressing (green) COS-7 cells were ATP depleted (30 minutes),
immunostained for p300 (a HAT), SC35 (nuclear speckle marker) or polII0 (active
transcription site marker), and DAPI co-stained. Confocal images (A) are of representative
cell nuclei from one of three independent experiments. Scale bar = 5 μm. The extent of co-
localization of IL-1α-GFP with nuclear proteins and DNA (DAPI) was assessed using
Pearson’s co-localization analysis (B). Data are from n ≥ 20 cells per co-stain.
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